Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07901491
NA

SUVY VerSus SAccharose (SUVISA)

Sponsor: Minerais SAS

View on ClinicalTrials.gov

Summary

Sugar substitutes are increasingly used to reduce sugar intake. SÜVY is a food ingredient combining erythritol and polydextrose. This study compares the blood sugar response, insulin response, and platelet activity after drinking a solution of SÜVY (50 g) versus a solution of regular sugar (sucrose, 50 g) in 14 healthy adults. Each participant takes part in two visits separated by at least 7 days, receiving one product per visit in random order. The goal is to evaluate whether SÜVY produces a lower blood sugar response than sucrose, and whether it has any effect on blood clotting markers.

Official title: Glycemic, Insulinemic and Platelet Reactivity Response After Oral Ingestion of SÜVY Versus Sucrose in Healthy Non-Diabetic Volunteers

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

14

Start Date

2026-11-09

Completion Date

2027-03

Last Updated

2026-10-28

Healthy Volunteers

Yes

Interventions

OTHER

SÜVY

Single oral dose of 50 g SÜVY, a proprietary ingredient consisting of a single fixed formulation of erythritol (E968) and polydextrose (E1200), administered as one product, dissolved in 250 mL still water.

OTHER

Sucrose

Single oral dose of 50 g sucrose dissolved in 250 mL still water.

Locations (1)

Centre d'Investigation Clinique - CHU de Rennes - Hôpital Pontchaillou

Rennes, Ille-et-Vilaine, France